Neuroscience

NeuLogiq® Platform Confirms Electrophysiological Marker of Target Engagement in Patients with Major Depressive Disorder

Data presented by Delix Therapeutics at the 2025 American Society of Clinical Psychopharmacology (ASCP) Conference confirms the NeuLogiq® Platform is…

7 months ago

Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals

New video series explores the impact of ADHD on relationships and the role of Qelbree in helping Jay’s ADHD symptom…

7 months ago

Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders

Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani…

7 months ago

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a…

7 months ago

O’Shaughnessy Ventures Backs AI-Powered Dream Reconstruction

Ninon Lizé Masclef awarded $100,000 fellowship to turn brain-wave data into 3D visualizations of dreams GREENWICH, Conn., May 23, 2025 /PRNewswire/…

7 months ago

Corundum Neuroscience and Corundum Systems Biology to Host Panel Sessions at First Ever SXSW London

Discussions to Focus on the Role of Sleep Innovation for Brain Health and the Influence of the Microbiome on Human…

7 months ago

Neurophet Participates ASNR 2025: Showcasing Clinical Utility of ‘Neurophet AQUA AD’

Co-CEO Jake Junkil Been joins Industry Collaboration Session to present Neurophet's brain imaging analysis technologies, including Neurophet AQUA ADCompany accelerates…

7 months ago

Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, May…

7 months ago

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery…

7 months ago